Drug name - Intuniv
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US6811794
(Pediatric) | TAKEDA PHARMS USA | Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles |
Jan, 2023
(2 months from now) | |
Drugs and Companies using GUANFACINE HYDROCHLORIDE ingredient
Treatment: NA
Dosage: TABLET, EXTENDED RELEASE;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 1MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription |
| EQ 2MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription |
| EQ 3MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription |
| EQ 4MG BASE | TABLET, EXTENDED RELEASE;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.